ABVC BioPharma, Inc. (ABVC)
USD 0.49
(0.73%)
USD 0.49
(0.73%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 152.43 Thousand | 969.78 Thousand | 355.79 Thousand | 483.04 Thousand | 701.71 Thousand | 6956.00 |
| Cost of Revenue | 302.03 Thousand | 286.41 Thousand | 5086.00 | 18.71 Thousand | 20.13 Thousand | 185.28 Thousand |
| Gross Profit | -149.6 Thousand | 683.36 Thousand | 350.71 Thousand | 464.32 Thousand | 681.58 Thousand | -178.32 Thousand |
| Operating Expenses | 8.06 Million | 15.79 Million | 11.69 Million | 8.97 Million | 4.14 Million | 1.39 Million |
| Selling, General and Administrative Expenses | 7 Million | 13.1 Million | 11.05 Million | 8.42 Million | 3.09 Million | 723.94 Thousand |
| Research and Development Expenses | 1.06 Million | 2.69 Million | 1 Million | 549.65 Thousand | 1.04 Million | 669.66 Thousand |
| Other Expenses | - | 83 Thousand | -360.89 Thousand | 199.64 Thousand | 116.84 Thousand | - |
| Cost and Expenses | 8.36 Million | 16.08 Million | 11.7 Million | 8.98 Million | 4.16 Million | 1.39 Million |
| Operating Income | -8.21 Million | -15.11 Million | -11.34 Million | -8.5 Million | -3.45 Million | -1.39 Million |
| Interest Expense | 2.49 Million | 293.96 Thousand | 227.21 Thousand | 405.03 Thousand | 482.01 Thousand | 155.93 Thousand |
| Income Tax Expense | 256 Thousand | 797.77 Thousand | 825.02 Thousand | -220.35 Thousand | -77.04 Thousand | 1850.00 |
| Earnings before Tax | -10.65 Million | -15.51 Million | -11.21 Million | -10.81 Million | -4.01 Million | -4.09 Million |
| Net Income | -10.51 Million | -16.31 Million | -12.03 Million | -10.59 Million | -3.93 Million | -4.1 Million |
| Earnings Per Share Basic | -2.43 | -5.15 | -4.80 | -5.37 | -2.25 | -3.53 |
| Earnings Per Share Diluted | -2.43 | -5.15 | -4.80 | -5.37 | -2.25 | -3.45 |
| Weighted Average Shares Outstanding | 4.33 Million | 3.16 Million | 2.5 Million | 1.97 Million | 1.74 Million | 1.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.33 Million | 3.16 Million | 2.5 Million | 1.97 Million | 1.74 Million | 1.18 Million |
| Gross Margin | -0.98 | 0.70 | 0.99 | 0.96 | 0.97 | -25.64 |
| EBIT Margin | -53.35 | -15.28 | -31.28 | -16.97 | -4.65 | -200.33 |
| Profit Margin | -68.99 | -16.82 | -33.83 | -21.93 | -5.61 | -589.61 |
| EBITDA | -8.13 Million | -15.19 Million | -10.97 Million | -10.37 Million | -3.47 Million | -2.74 Million |
| Earnings Before Tax Margin | -53.90 | -15.59 | -31.89 | -17.61 | -4.93 | -200.35 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 117.14 Thousand | 1205.00 | 2165.00 | 152.43 Thousand | 15.88 Thousand | 6109.00 |
| Cost of Revenue | 13.49 Thousand | 1563.00 | 146.78 Thousand | 330.56 Thousand | 29.61 Thousand | 72.98 Thousand |
| Gross Profit | 103.64 Thousand | -358.00 | -144.62 Thousand | -178.13 Thousand | -13.73 Thousand | -66.87 Thousand |
| Operating Expenses | 1.08 Million | 3.44 Million | 1.81 Million | 8.03 Million | 2.14 Million | 2.12 Million |
| Selling, General and Administrative Expenses | 1.03 Million | 3.37 Million | 1.74 Million | - | 1.99 Million | 1.61 Million |
| Research and Development Expenses | 40.4 Thousand | 69.06 Thousand | 72.18 Thousand | - | 141.31 Thousand | 514.44 Thousand |
| Other Expenses | 22.67 Thousand | 30.48 Thousand | 16.55 Thousand | 69.28 Thousand | -10.76 Thousand | 38.32 Thousand |
| Cost and Expenses | 1.09 Million | 3.44 Million | 1.96 Million | 8.36 Million | 2.17 Million | 2.19 Million |
| Operating Income | -976.64 Thousand | -3.44 Million | -1.96 Million | -8.21 Million | -2.15 Million | -2.19 Million |
| Interest Expense | 260.03 Thousand | 684.68 Thousand | 1.1 Million | 2.49 Million | 1.21 Million | 114.75 Thousand |
| Income Tax Expense | -110.89 Thousand | -3.93 Million | 175.31 Thousand | 256 Thousand | -999.00 | 81.69 Thousand |
| Earnings before Tax | -1.38 Million | -3.98 Million | -3.15 Million | -10.65 Million | -3.36 Million | -2.23 Million |
| Net Income | -1.01 Million | -3.93 Million | -3.11 Million | -10.51 Million | -3.31 Million | -2.26 Million |
| Earnings Per Share Basic | -0.09 | -0.40 | -0.39 | - | -0.82 | -0.68 |
| Earnings Per Share Diluted | -0.09 | -0.40 | -0.39 | - | -0.82 | -0.68 |
| Weighted Average Shares Outstanding | 11.32 Million | 9.73 Million | 7.94 Million | 4.33 Million | 4.05 Million | 3.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.32 Million | 9.73 Million | 7.94 Million | 4.33 Million | 4.05 Million | 3.3 Million |
| Gross Margin | 0.88 | -0.30 | -66.80 | -1.17 | -0.86 | -10.95 |
| EBIT Margin | -8.22 | -2857.34 | -902.55 | - | -133.34 | -342.69 |
| Profit Margin | -8.64 | -3263.88 | -1436.92 | -68.99 | -208.86 | -370.52 |
| EBITDA | -963.34 Thousand | -3.44 Million | -1.95 Million | - | -2.11 Million | -2.09 Million |
| Earnings Before Tax Margin | -8.34 | -2858.41 | -906.06 | -53.90 | -135.66 | -359.12 |
9212
LPCN
2809
LWSOF
TKKYY
GRAM